Baxter
BAX
$41.29
Share price
-0.12%
Change (1 day)
-45.71%
Change (1 year)
Categories
Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
Baxter (BAX) - Total debt
Total debt on the balance sheet as of March 2023 : $16.88 B
According to Baxter's latest financial reports the company's total debt is $16.88 B. A company’s total debt is the sum of all current and non-current debts.
Baxter - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $17.21 B | -5.99% |
| 2021-12-31 | $18.31 B | 169.11% |
| 2020-12-31 | $6.80 B | 14.14% |
| 2019-12-31 | $5.96 B | 71.44% |
| 2018-12-31 | $3.47 B | -1% |
| 2017-12-31 | $3.51 B | 26.24% |
| 2016-12-31 | $2.78 B | -57.33% |
| 2015-12-31 | $6.52 B | -29.93% |
| 2014-12-31 | $9.30 B | 1.52% |
| 2013-12-31 | $9.16 B | 54.57% |
| 2012-12-31 | $5.93 B | 14.15% |
| 2011-12-31 | $5.19 B | 18.42% |
| 2010-12-31 | $4.38 B | 5.69% |
| 2009-12-31 | $4.15 B | 10.52% |
| 2008-12-31 | $3.75 B | 21.59% |
| 2007-12-31 | $3.08 B | 10.28% |
| 2006-12-31 | $2.80 B | -16.09% |
| 2005-12-31 | $3.33 B | -22.26% |
| 2004-12-31 | $4.29 B | -6.12% |
| 2003-12-31 | $4.57 B | -1.57% |
| 2002-12-31 | $4.64 B | 72.94% |
| 2001-12-31 | $2.68 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | $28.12 B | 66.55% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $35.25 B | 108.76% | 🇺🇸 USA |
 Becton Dickinson BDX | $18.22 B | 7.90% | 🇺🇸 USA |
 Boston Scientific BSX | $9.28 B | -45.04% | 🇺🇸 USA |
 Stryker Corporation SYK | $11.85 B | -29.79% | 🇺🇸 USA |
 Cardinal Health CAH | $5.26 B | -68.84% | 🇺🇸 USA |
 ICU Medical
ICUI | $1.73 B | -89.73% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $1.50 B | -91.08% | 🇺🇸 USA |
 Owens & Minor
OMI | $2.69 B | -84.02% | 🇺🇸 USA |
 CryoLife CRY | N/A | N/A | 🇺🇸 USA |